| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate |
2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3252311319717ac57cdc7d724229dc0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c21245c9b7ad5e0e697c4fb12257e61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffbcccacab1775943231305461bd9220 |
| publicationDate |
2017-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017037741-A1 |
| titleOfInvention |
Compact solid dosage form of aspirin and clopidogrel |
| abstract |
The present invention provides a solid dosage form comprising two active pharmaceutical agents; acetylsalicylic acid and clopidogrel or pharmaceutically acceptable salts thereof, wherein the total amount of these active pharmaceutical agents present in the solid dosage form is more than 55% of the total weight of the solid dosage form, and wherein clopidogrel is released immediately upon contact with aqueous environment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115212180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109288805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107308157-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109288805-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107669690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107693524-A |
| priorityDate |
2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |